MarketInOut Stock Screener Log In | Sign Up

Nascent Biotech Inc

OTC • Healthcare • Biotechnology • Quote as of 10/30/2026
Nascent Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0344 mln
Float135 mln
Earnings Date06/30/2025

Relative Strength

5 / 100
Severely lagging

ROE

269
Extraordinary

ROA

-854
Deeply negative

Business Description

Nascent Biotech Inc. is a Florida-based medicine company focused on finding new treatments for serious illnesses. Its main work involves creating specialized proteins that target cancer cells, including a treatment called Pritumumab aimed at helping patients with brain tumors. The company also owns a platform called MultiPharm, which it uses to develop therapies for conditions beyond cancer, such as diabetes and organ transplantation.

Key Fundamentals

EPS-0.01
ROE269
ROIC1,662
ROA-854
Interest Cover-5.79
EBITDA, mln-0.59
EV / EBITDA-0.41
Revenue, mln0.00

Quote Details

Last 0.0002
Change 0 (0%)
Open 0.0002
Volume 10,000
Turnover 2
Average Volume 75,021

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 57 / 100   
1 Month -60% 2 / 100   
2 Months -99.76% 0 / 100   
6 Months -99.55% 0 / 100   
1 Year -99.77% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog